Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oesophageal Cancer Nos”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05497947
What this trial is testing

Evaluation of the French Translation of Swallowing (SOAL-VF) Patient Reported Outcomes (PRO) After Total PharyngoLaryngectomy

Who this might be right for
Pharyngeal CancerSwallowing DisorderLarynx Cancer
Centre Hospitalier de Valence 225
Large-scale testing (Phase 3)Ended earlyNCT00824785
What this trial is testing

REAL3 Trial of Efficacy of EOX With/Without Panitumumab in Previously Untreated Adv OG Cancer

Who this might be right for
Oesophago-gastric Cancer
Royal Marsden NHS Foundation Trust 574
Not applicableUnknownNCT00155805
What this trial is testing

Immunologic Factors in Reflux Esophagitis and Barrett's Esophagus

Who this might be right for
Reflux EsophagitisHiatal Hernia
National Taiwan University Hospital 90
Early research (Phase 1)Looking for participantsNCT07181473
What this trial is testing

Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors

Who this might be right for
Lung Cancer (NSCLC)Prostate CancerEsophageal Cancer+1 more
Phrontline Biopharma 200
Testing effectiveness (Phase 2)UnknownNCT03585673
What this trial is testing

Docetaxel-polymeric Micelles(PM) and Oxaliplatin for Esophageal Carcinoma

Who this might be right for
Esophagus Squamous Cell Carcinoma (SCC)Metastatic Cancer
Sung Yong Oh 38
Large-scale testing (Phase 3)Ended earlyNCT04689594
What this trial is testing

Evaluate the Esophageal Stenosis Inhibition Effects of CLS2702C/CLS2702D After Endoscopic Submucosal Dissection (ESD) in Patients With Superficial Esophageal Cancer in the Steroid Administration Risk Group

Who this might be right for
Superficial Esophageal Cancer
CellSeed Inc. 1
Large-scale testing (Phase 3)Study completedNCT00002631
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Cancer of the Esophagus

Who this might be right for
Esophageal Cancer
Radiation Therapy Oncology Group 298
Early research (Phase 1)Enrolling By InvitationNCT07218003
What this trial is testing

A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4

Who this might be right for
Non Small Cell Lung CancerCervical CancerHead and Neck Squamous Cell Cancer+7 more
Rondo Therapeutics 149
Not applicableLooking for participantsNCT06792786
What this trial is testing

Prospective Study Evaluating Concurrent Chemoradiotherapy Following Induction Immunochemotherapy for Esophageal Cancer Based on Dynamic ctDNA Monitoring

Who this might be right for
Esophageal CancerctDNA
The Central Hospital of Lishui City 30
Testing effectiveness (Phase 2)Study completedNCT00948961
What this trial is testing

CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1

Who this might be right for
Advanced Malignancies
Celldex Therapeutics 70
Not applicableLooking for participantsNCT06979869
What this trial is testing

Investigating Multigene Methylation Dynamics in Treatment Response Surveillance for Esophageal Carcinoma

Who this might be right for
Esophageal Cancer
Xijing Hospital 300
Testing effectiveness (Phase 2)Temporarily pausedNCT00048529
What this trial is testing

Study of T900607-Sodium in Subjects With Previously Treated Gastric Cancer or Adenocarcinoma of the Esophagus

Who this might be right for
Gastric CancerEsophageal Neoplasms
Tularik 70
Not applicableUnknownNCT06365866
What this trial is testing

Evaluate the Efficacy of Adding Intraluminal Brachytherapy After CCRT for Local-regional Thoracic Esophageal Cancer.

Who this might be right for
Esophageal NeoplasmsHead and Neck NeoplasmsGastrointestinal Neoplasms+6 more
Taipei Veterans General Hospital, Taiwan 20
Early research (Phase 1)Ended earlyNCT03144661
What this trial is testing

An Open-Label Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies

Who this might be right for
Hepatocellular Carcinoma (HCC)CholangiocarcinomaEsophageal Cancer+3 more
Incyte Corporation 25
Early research (Phase 1)Looking for participantsNCT06010862
What this trial is testing

Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors

Who this might be right for
Gastric CancerColon CancerPancreas Cancer+4 more
Chongqing Precision Biotech Co., Ltd 36
Testing effectiveness (Phase 2)Study completedNCT03929666
What this trial is testing

A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer

Who this might be right for
HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer
Jazz Pharmaceuticals 74
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07126561
What this trial is testing

Trastuzumab Deruxtecan to Treat HER2 + Newly Diagnosed Metastatic GI Cancers

Who this might be right for
HER2 Positive Newly Diagnosed Metastatic Esophageal, Gastric, GEJ Cancer Patients With an ECOG Performance Status of 2
University of Chicago 43
Testing effectiveness (Phase 2)Study completedNCT01787006
What this trial is testing

Definitive Radiochemotherapy Plus/Minus Cetuximab in Unresectable Locally Advanced Esophageal Cancer

Who this might be right for
Esophageal Cancer
University Hospital Schleswig-Holstein 74
Early research (Phase 1)Active Not RecruitingNCT07118176
What this trial is testing

Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers

Who this might be right for
Anal CarcinomaBladder CarcinomaBreast Carcinoma+31 more
Jonsson Comprehensive Cancer Center 30
Not applicableStudy completedNCT05688761
What this trial is testing

Nordic Gastric and Esophageal Tumor Study

Who this might be right for
Cancer of StomachCancer of the EsophagusDrug Use
Karolinska Institutet 900,000
Next Page